Nitric oxide, oxidant status and antioxidant response in morbidly obese patients: The impact of 1-year surgical weight loss

Obesity Surgery

Volumn 23, Issue 11, 2013, Pages 1858-1863

  Cătoi, Adriana Florinela ^a   Pârvu, Alina ^a   Galea, Romeo Florin ^a   Pop, Ioana Delia ^b   Mureşan, Adriana ^a   Cǎtoi, Cornel ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

Author keywords

Bariatric surgery; Morbid obesity; Nitric oxide; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROPLASTY; HUMAN; MALE; MORBID OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SILASTIC RING; SURGICAL EQUIPMENT; WEIGHT REDUCTION;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; GASTROPLASTY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NITRIC OXIDE; OBESITY, MORBID; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; ROMANIA; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84885446496     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0968-1     Document Type: Article

References (33)

1. Low S, Chew Chin M, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore. 2009;38:57-65.
2. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010;535918:1-17.
3. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12:3117-32.
4. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1-16.
5. Martínez JA. Mitochondrial oxidative stress and inflammation: a slalom to obesity and insulin resistance. J Physiol Biochem. 2006;62(4):303-6.
6. Keaney JF, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434-9.
7. Kwang KK, Pyung CO, Quon MJ. Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res. 2009;81:649-59.
8. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clinica Chimica Acta. 2005;360:9-26.
9. Noroha BT, Li JM, Wheatcroft SB, et al. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 2005;54:1082-9.
10. Joost HG, Tschop MH. NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity? Endocrinology. 2007;148(10):4545-7.
11. Iyer A, Fairlie DP, Prins JB, et al. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol. 2010;6:71-82.
12. Grattagliano I, Palmieri VO, Portincasa P, et al. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem. 2008;19:491-504.
13. Ward M, Prachand V. Surgical treatment of obesity. Gastrointest Endosc. 2009;70(5):985-90.
14. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-56.
15. Deitel M. The early effect of the bariatric operations on diabetes. Obes Surg. 2002;12:349.
16. Lin LY, Lee WJ, Shen HN, et al. Nitric oxide production is paradoxically decreased after weight reduction surgery in morbid obesity patients. Atherosclerosis. 2007;190:436-42.
17. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J, et al. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity. Metabolism. 2004;53(10):1268-73.
18. Pardina E, Ferrer R, Baena-Fustegueras JA, et al. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg. 2010;20:623-32.
19. Sledzinski T, Sledzinski M, Smolenski RT, et al. Increased serum nitric oxide concentration after bariatric surgery - a potential mechanism for cardiovascular benefit. Obes Surg. 2010;20:204-10.
20. World Medical Association Declaration of Helsinki. Bull of the World Health Organization. 2001;79(4):373-4.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem. 1972;18:499-500.
22. Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. J Med Sci Res. 2007;2:29-32.
23. Miranda K, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide: Biol and Chem. 2001;5(1):62-71.
24. Ozcan E. A new automated colorimetric method for measuring total oxidant status. Clinical Biochem. 2005;38(12):1103-11.
25. Ozcan E. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochem. 2004;37:112-9.
26. Codoner-Franch P, Tavárez-Alonso S, Murria-Estal R, et al. Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation. Atherosclerosis. 2011;215:475-80.
27. Da Silva VRG, Moreira EAM, Wilhelm-Filho D, et al. Proinflammatory and oxidative stress markers in patients submitted to Roux-en-Y gastric bypass after 1 year of follow-up. European Journal of Clinical Nutrition. 2012; 1-9
28. Choi WJ, Pai SH, Kim SK, et al. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem. 2001;47(6):1106-9.
29. Cabrera EJ, Valezi AC, Delfino VDA, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux en-Y gastric bypass. Obes Surg. 2010;20:42-9.
30. Maniscalco M, de Laurentiis G, Zedda A, et al. Exhaled nitric oxide in severe obesity: effect of weight loss. Respir Physiol & Neurobiol. 2007;156:370-3.
31. van Dielen FMH, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89:4062-8.
32. Pardina E, Ferrer R, Baena-Fustegueras JA. Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg. 2012;22:131-9.
33. Pardina E, Lecube A, Llamas R, et al. Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients. Obes Surg. 2009;19:1150-8.